Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies. J of Skin [Internet]. 2021 Nov. 5 [cited 2025 May 18];5(6):s63. Available from: https://skin.dermsquared.com/skin/article/view/1414